HIV
Conference Coverage
One-month TB-prevention regimen effective in HIV+ individuals
New, shorter TB regimen is effective and could up adherence in HIV-positive individuals.
Conference Coverage
Bloating. Flatulence. Think SIBO
Conference Coverage
VIDEO: The return of Kaposi’s sarcoma
SAN DIEGO – Once again, dermatologists are seeing more cases of Kaposi’s sarcoma in HIV-positive patients, according to Toby Maurer, MD.
Latest News
Inflammatory markers predict vaccine response in HCV, HIV
Study investigates response to HAV, HBV, tetanus vaccines.
From the Journals
Gut-homing protein predicts HIV-acquisition, disease progression in women
Integrin alpha4beta7 expression predicts HIV acquisition and disease progression in women.
From the Journals
Large-vessel vasculitis: More severe in HIV-infected patients
Large-vessel vasculitis was more severe in HIV-infected individuals.
From the Journals
Growing old with HIV: What’s likely, and how can physicians help?
As HIV-infected individuals age, comorbidities will become an increasing challenge.
News
FDA approves new combination drug for HIV patients
A new single pill combination drug was approved to treat HIV-1 infections in virologically suppressed adults.
News
FDA approves complete combo tablet for HIV
Symfi Lo was approved as a complete combo tablet for the treatment of HIV in adults and children.
News
nPEP for HIV: Updated CDC guidelines available for primary care physicians
To be effective, PEP needs to be initiated within 72 hours of exposure, but many people don’t know about this option.
From the Journals
Trial seeks improved regimens for pregnant women with HIV
A new study seeks better-tolerated alternatives to the current antiretroviral regimen for pregnant women with HIV.